Gilead Historical Income Statement

GILD Stock  USD 73.01  0.60  0.83%   
Historical analysis of Gilead Sciences income statement accounts such as Gross Profit of 28.5 B or Other Operating Expenses of 20.5 B can show how well Gilead Sciences performed in making a profits. Evaluating Gilead Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Gilead Sciences's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Gilead Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Gilead Sciences is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.

About Gilead Income Statement Analysis

Gilead Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Gilead Sciences shareholders. The income statement also shows Gilead investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Gilead Sciences Income Statement Chart

Gilead Sciences Income Statement is one of the three primary financial statements used for reporting Gilead's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Gilead Sciences revenue and expense. Gilead Sciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Gilead Sciences' Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 20.5 B, whereas Interest Expense is forecasted to decline to about 534.5 M.

Total Revenue

Total revenue comprises all receipts Gilead Sciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Gilead Sciences minus its cost of goods sold. It is profit before Gilead Sciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Gilead Sciences. It is also known as Gilead Sciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Gilead Sciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Gilead Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.At present, Gilead Sciences' Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 20.5 B, whereas Interest Expense is forecasted to decline to about 534.5 M.
 2021 2022 2023 2024 (projected)
Total Revenue27.3B27.3B27.1B28.5B
Interest Expense1.0B935M944M534.5M

Gilead Sciences income statement Correlations

0.430.210.010.040.250.250.370.140.130.22-0.020.190.440.18-0.140.010.060.17-0.38-0.050.130.0-0.31-0.220.65
0.430.770.680.770.390.40.480.780.80.33-0.10.220.370.770.680.320.130.080.22-0.110.050.56-0.440.37-0.02
0.210.770.980.80.70.710.760.850.780.65-0.090.610.290.680.810.110.59-0.090.27-0.11-0.110.43-0.10.4-0.3
0.010.680.980.810.660.680.70.820.770.62-0.10.580.20.650.850.120.6-0.130.35-0.11-0.150.44-0.010.46-0.44
0.040.770.80.810.140.170.230.950.990.12-0.150.12-0.140.910.950.540.13-0.090.48-0.45-0.430.84-0.030.69-0.57
0.250.390.70.660.141.00.990.260.130.970.140.90.650.080.2-0.50.860.1-0.140.360.39-0.31-0.16-0.190.2
0.250.40.710.680.171.00.990.280.160.970.120.90.640.10.23-0.480.860.08-0.120.340.36-0.29-0.14-0.160.18
0.370.480.760.70.230.990.990.350.230.950.10.880.650.170.26-0.410.830.08-0.120.290.32-0.21-0.17-0.130.21
0.140.780.850.820.950.260.280.350.910.24-0.10.220.010.80.920.410.2-0.20.5-0.33-0.340.75-0.090.69-0.51
0.130.80.780.770.990.130.160.230.910.1-0.170.11-0.120.960.890.560.1-0.010.38-0.48-0.420.84-0.070.62-0.47
0.220.330.650.620.120.970.970.950.240.10.360.940.630.080.16-0.520.910.24-0.080.370.42-0.35-0.17-0.190.15
-0.02-0.1-0.09-0.1-0.150.140.120.1-0.1-0.170.360.370.19-0.05-0.23-0.290.380.710.150.260.41-0.32-0.25-0.17-0.01
0.190.220.610.580.120.90.90.880.220.110.940.370.360.110.13-0.440.980.25-0.130.10.2-0.280.08-0.140.12
0.440.370.290.2-0.140.650.640.650.01-0.120.630.190.36-0.14-0.1-0.530.280.19-0.180.810.77-0.47-0.71-0.430.44
0.180.770.680.650.910.080.10.170.80.960.08-0.050.11-0.140.750.520.10.220.22-0.53-0.370.76-0.110.46-0.34
-0.140.680.810.850.950.20.230.260.920.890.16-0.230.13-0.10.750.490.16-0.280.6-0.31-0.370.780.010.76-0.68
0.010.320.110.120.54-0.5-0.48-0.410.410.56-0.52-0.29-0.44-0.530.520.49-0.38-0.210.36-0.65-0.560.870.060.63-0.4
0.060.130.590.60.130.860.860.830.20.10.910.380.980.280.10.16-0.380.23-0.060.090.16-0.260.12-0.11-0.03
0.170.08-0.09-0.13-0.090.10.080.08-0.2-0.010.240.710.250.190.22-0.28-0.210.23-0.230.090.42-0.23-0.38-0.460.3
-0.380.220.270.350.48-0.14-0.12-0.120.50.38-0.080.15-0.13-0.180.220.60.36-0.06-0.23-0.03-0.190.480.040.74-0.73
-0.05-0.11-0.11-0.11-0.450.360.340.29-0.33-0.480.370.260.10.81-0.53-0.31-0.650.090.09-0.030.81-0.68-0.56-0.460.22
0.130.05-0.11-0.15-0.430.390.360.32-0.34-0.420.420.410.20.77-0.37-0.37-0.560.160.42-0.190.81-0.6-0.71-0.610.45
0.00.560.430.440.84-0.31-0.29-0.210.750.84-0.35-0.32-0.28-0.470.760.780.87-0.26-0.230.48-0.68-0.60.050.76-0.54
-0.31-0.44-0.1-0.01-0.03-0.16-0.14-0.17-0.09-0.07-0.17-0.250.08-0.71-0.110.010.060.12-0.380.04-0.56-0.710.050.35-0.23
-0.220.370.40.460.69-0.19-0.16-0.130.690.62-0.19-0.17-0.14-0.430.460.760.63-0.11-0.460.74-0.46-0.610.760.35-0.66
0.65-0.02-0.3-0.44-0.570.20.180.21-0.51-0.470.15-0.010.120.44-0.34-0.68-0.4-0.030.3-0.730.220.45-0.54-0.23-0.66
Click cells to compare fundamentals

Gilead Sciences Account Relationship Matchups

Gilead Sciences income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization1.9B1.5B2.1B3.1B(1.8B)(1.7B)
Interest Expense995M984M1.0B935M944M534.5M
Total Revenue22.4B24.7B27.3B27.3B27.1B28.5B
Gross Profit17.8B20.1B20.7B21.6B27.1B28.5B
Other Operating Expenses18.2B14.8B17.2B16.3B19.5B20.5B
Operating Income4.3B7.0B7.4B7.3B7.6B4.4B
Ebit4.3B7.0B7.4B7.3B7.6B4.4B
Ebitda6.2B8.5B9.5B10.4B7.6B4.9B
Cost Of Revenue4.7B4.6B6.6B5.7B5.8B6.1B
Total Operating Expenses13.5B10.2B10.6B10.7B11.8B12.4B
Income Before Tax5.2B1.7B8.3B5.8B6.9B4.2B
Total Other Income Expense Net873M(5.4B)872M(1.5B)(746M)(708.7M)
Net Income5.4B89M6.2B4.6B5.7B3.0B
Income Tax Expense(204M)1.6B2.1B1.2B(1.2B)(1.2B)
Research Development9.1B5.0B5.4B5.0B5.7B6.0B
Selling General Administrative3.6B4.4B4.5B4.9B6.5B6.8B
Net Income Applicable To Common Shares5.4B123M6.2B4.6B5.3B4.9B
Net Income From Continuing Ops5.4B89M6.2B4.6B5.8B6.6B
Non Operating Income Net Other1.9B(1.4B)(639M)(581M)(522.9M)(496.8M)
Minority Interest(22M)(34M)24M26M47M49.4M
Tax Provision(204M)1.6B2.1B1.2B1.4B2.2B
Net Interest Income(995M)(984M)(1.0B)(935M)(918M)(963.9M)
Reconciled Depreciation1.4B1.5B2.1B2.1B2.5B1.9B

Gilead Sciences Investors Sentiment

The influence of Gilead Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Gilead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Gilead Sciences' public news can be used to forecast risks associated with an investment in Gilead. The trend in average sentiment can be used to explain how an investor holding Gilead can time the market purely based on public headlines and social activities around Gilead Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Gilead Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Gilead Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Gilead Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Gilead Sciences.

Gilead Sciences Implied Volatility

    
  24.93  
Gilead Sciences' implied volatility exposes the market's sentiment of Gilead Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gilead Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gilead Sciences stock will not fluctuate a lot when Gilead Sciences' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gilead Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gilead Sciences' short interest history, or implied volatility extrapolated from Gilead Sciences options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.